立即打开
除了呼吸机,国外医院又有一关键物资告急

除了呼吸机,国外医院又有一关键物资告急

Jeremy Kahn 2020-04-08
根据患者数量及其需要的氧气量估算,医院的储备很快将被耗尽,而氧气厂商则很难跟上需求的步伐。

氧气供应成了抗击新冠疫情的最新瓶颈。

许多感染新冠病毒后住院的患者都有肺部感染并且需要输氧,其中甚至包括那些病情还未严重到需要上呼吸机的患者。

根据这些患者的数量及其需要的氧气量估算,医院的储备很快将被耗尽,而氧气厂商则很难跟上需求的步伐。

医院通常建有大型集中式液氧储罐,其中的液氧经气化后通过管道输送到医院各处。有些医院还会使用小容量液氧瓶。

但在意大利,有报道称由于需要呼吸机及其他方式输氧的病患人数激增,新冠疫情期间医院的氧气日用量已经增长了两倍以上。在意大利北部疫情最严重的地区,有些医院已经被迫安装了新的大型液氧储罐,以确保氧气供应充足。

在英国,据称伦敦一家大型医院的氧气上周末就将消耗殆尽。受此影响,英国国家医疗服务体系(NHS)紧急发函,要求医生计算自家医院氧气能同时满足的患者人数,同时限制CPAP(持续气道正压呼吸机)的使用。CPAP的作用是帮助那些病情还未严重到需要呼吸机的患者。

马德里一家医院的急诊科外,一位工作人员推着一车氧气瓶。新冠疫情期间,许多医院的氧气供应都即将耗尽,这可能让患者的生命受到威胁。图片来源:Paul Hanna—Bloomberg/Getty Images

CPAP及其他被称为“经鼻高流量氧疗”的治疗方式是将氧气管插入患者鼻孔后直接输氧,其每小时氧气消耗量往往远高于呼吸机。NHS称,过多病患同时使用这样的治疗方法还可能让医院的氧气管网压力失衡,从而使整个管网突然失灵,而这会让医院中所有使用壁式供氧装置的患者陷入危险之中。

NHS的警告表明,就算英国能为新冠肺炎患者生产出足够的呼吸机,氧气的供应问题也将成为一大限制。

与此同时,纽约市的许多医生都说自己的医院也处于管道氧气即将耗尽的危险境地。有报道称,因为所有的管道氧气供氧设备都已被占用,一些医院开始用氧气瓶治疗患者,而医生表示氧气瓶的数量也不多了。

总部设在新泽西州克拉克镇的全球供应链咨询公司GEP副总裁比瑞·莫汉是制药和医疗保健行业专家。他说对医疗氧气需求量增幅的预测范围很大,介于25%-500%之间。莫汉指出,大多数氧气厂商平时会保留约20%的后备产能,他们应该有能力满足医院需求的增长,特别是在建筑、石油和天然气等其他行业的氧气需求因经济陷入停滞而直线下降的时候。

取自空气

理论上,有几个因素限制着氧气厂商的产量。大多数生产商都用空气制氧。他们将空气过滤后采用低温制氧工艺,也就是用空气压缩机将空气温度降至极低水平,然后将其中的氧气、氮气等分离出来。分离出的气体还将进一步净化和纯化为液体,或者装入压力储罐和小型氧气瓶中。大多数工序都由基本的物理反应和热反应推动,几乎不使用化学原料。

莫汉说,更大的实际问题在于医院接受的通常都是液氧,他们随后会把液氧气化,然后通过管道输送到医院各处。而医院的液氧储存能力有限,因此运输车辆必须往返更多次才能保持医院的液氧储备水平。

本月初,英国重症监护协会负责人、加内什·孙塔拉林加姆医生在英国麻醉医师协会主办的在线研讨会上说,大多数医院的氧气储罐都装有传感器,当氧气量降至一定水平时传感器就会自动订购氧气。但由于氧气消耗速度远高于正常水平,再加上如此多的医院同时出现大量需求,“让医院的氧气不耗尽,这很难做到”。

他指出,某些情况下医院可能会发现自己的氧气储备会在“几小时而不是几天内”消耗完毕。

莫汉认为,医院应有可能借助工业用户通常使用的大型氧气瓶为自己的氧气管网供氧,但此举面临一些监管障碍,原因是此类氧气瓶并未获准用于医疗。全球最大医用气体生产商之一法国液化空气集团已经表示,它正在考虑就此向监管部门提出申请。

在英国,政府已经要求氧气生产企业、NHS官方供应商BOC将产量提高到原来的四倍,以便满足今后几周新冠肺炎患者数量达到峰值时的预期需求。BOC的母公司林德集团是全球最大工业气体制造商之一。BOC发表声明称:“BOC正在和英国政府部门密切合作,以便制定程序来应对与目前新冠疫情相关的气体需求增长。”

BOC表示,该公司一直在提高医用气体库存,而且也已经增加了向医院运气的罐车数量,目的就是为本次疫情做准备。英国军方也已处于待命状态,如果BOC的司机患病或自我隔离,军方将派人驾驶这些罐车。

BOC和法国液化空气集团均已要求使用氧气瓶的医疗行业客户归还空氧气瓶,以便他们为空瓶充气并再次输送出去。

Air Products也是一家大型工业气体制造商,总部设在宾夕法尼亚州阿伦敦。该公司发布公告称它“目前并未因为新冠疫情出现任何产品短缺”,而且“一直在检查和评估整个稳固的供应链、冗余后备方案以及设施网络,以便满足顾客需求。”

Air Products表示:“情况变化不定,因而很难预测其未来影响或确切的持续时间。”(财富中文网)

译者:Charlie

审校:夏林

氧气供应成了抗击新冠疫情的最新瓶颈。

许多感染新冠病毒后住院的患者都有肺部感染并且需要输氧,其中甚至包括那些病情还未严重到需要上呼吸机的患者。

根据这些患者的数量及其需要的氧气量估算,医院的储备很快将被耗尽,而氧气厂商则很难跟上需求的步伐。

医院通常建有大型集中式液氧储罐,其中的液氧经气化后通过管道输送到医院各处。有些医院还会使用小容量液氧瓶。

但在意大利,有报道称由于需要呼吸机及其他方式输氧的病患人数激增,新冠疫情期间医院的氧气日用量已经增长了两倍以上。在意大利北部疫情最严重的地区,有些医院已经被迫安装了新的大型液氧储罐,以确保氧气供应充足。

在英国,据称伦敦一家大型医院的氧气上周末就将消耗殆尽。受此影响,英国国家医疗服务体系(NHS)紧急发函,要求医生计算自家医院氧气能同时满足的患者人数,同时限制CPAP(持续气道正压呼吸机)的使用。CPAP的作用是帮助那些病情还未严重到需要呼吸机的患者。

CPAP及其他被称为“经鼻高流量氧疗”的治疗方式是将氧气管插入患者鼻孔后直接输氧,其每小时氧气消耗量往往远高于呼吸机。NHS称,过多病患同时使用这样的治疗方法还可能让医院的氧气管网压力失衡,从而使整个管网突然失灵,而这会让医院中所有使用壁式供氧装置的患者陷入危险之中。

NHS的警告表明,就算英国能为新冠肺炎患者生产出足够的呼吸机,氧气的供应问题也将成为一大限制。

与此同时,纽约市的许多医生都说自己的医院也处于管道氧气即将耗尽的危险境地。有报道称,因为所有的管道氧气供氧设备都已被占用,一些医院开始用氧气瓶治疗患者,而医生表示氧气瓶的数量也不多了。

总部设在新泽西州克拉克镇的全球供应链咨询公司GEP副总裁比瑞·莫汉是制药和医疗保健行业专家。他说对医疗氧气需求量增幅的预测范围很大,介于25%-500%之间。莫汉指出,大多数氧气厂商平时会保留约20%的后备产能,他们应该有能力满足医院需求的增长,特别是在建筑、石油和天然气等其他行业的氧气需求因经济陷入停滞而直线下降的时候。

取自空气

理论上,有几个因素限制着氧气厂商的产量。大多数生产商都用空气制氧。他们将空气过滤后采用低温制氧工艺,也就是用空气压缩机将空气温度降至极低水平,然后将其中的氧气、氮气等分离出来。分离出的气体还将进一步净化和纯化为液体,或者装入压力储罐和小型氧气瓶中。大多数工序都由基本的物理反应和热反应推动,几乎不使用化学原料。

莫汉说,更大的实际问题在于医院接受的通常都是液氧,他们随后会把液氧气化,然后通过管道输送到医院各处。而医院的液氧储存能力有限,因此运输车辆必须往返更多次才能保持医院的液氧储备水平。

本月初,英国重症监护协会负责人、加内什·孙塔拉林加姆医生在英国麻醉医师协会主办的在线研讨会上说,大多数医院的氧气储罐都装有传感器,当氧气量降至一定水平时传感器就会自动订购氧气。但由于氧气消耗速度远高于正常水平,再加上如此多的医院同时出现大量需求,“让医院的氧气不耗尽,这很难做到”。

他指出,某些情况下医院可能会发现自己的氧气储备会在“几小时而不是几天内”消耗完毕。

莫汉认为,医院应有可能借助工业用户通常使用的大型氧气瓶为自己的氧气管网供氧,但此举面临一些监管障碍,原因是此类氧气瓶并未获准用于医疗。全球最大医用气体生产商之一法国液化空气集团已经表示,它正在考虑就此向监管部门提出申请。

在英国,政府已经要求氧气生产企业、NHS官方供应商BOC将产量提高到原来的四倍,以便满足今后几周新冠肺炎患者数量达到峰值时的预期需求。BOC的母公司林德集团是全球最大工业气体制造商之一。BOC发表声明称:“BOC正在和英国政府部门密切合作,以便制定程序来应对与目前新冠疫情相关的气体需求增长。”

BOC表示,该公司一直在提高医用气体库存,而且也已经增加了向医院运气的罐车数量,目的就是为本次疫情做准备。英国军方也已处于待命状态,如果BOC的司机患病或自我隔离,军方将派人驾驶这些罐车。

BOC和法国液化空气集团均已要求使用氧气瓶的医疗行业客户归还空氧气瓶,以便他们为空瓶充气并再次输送出去。

Air Products也是一家大型工业气体制造商,总部设在宾夕法尼亚州阿伦敦。该公司发布公告称它“目前并未因为新冠疫情出现任何产品短缺”,而且“一直在检查和评估整个稳固的供应链、冗余后备方案以及设施网络,以便满足顾客需求。”

Air Products表示:“情况变化不定,因而很难预测其未来影响或确切的持续时间。”(财富中文网)

译者:Charlie

审校:夏林

Oxygen supplies have emerged as the latest choke point in the battle against the coronavirus.

Many patients hospitalized with COVID-19 infections, even those not sick enough to be placed on a mechanical ventilator, have impaired lung function and require supplemental oxygen.

The number of these patients—and the amount of oxygen they are requiring—is threatening to exhaust hospitals’ supply, and industrial gas producers are scrambling to keep pace with the demand.

Hospitals normally have large central tanks for the storage of liquid oxygen, which is then evaporated into a gas and piped throughout the facility. Some also use smaller canisters of liquid oxygen.

But in Italy, hospitals have reported their daily consumption of oxygen has more than tripled during the pandemic as the number of patients needing ventilators and other forms of supplemental oxygen has soared. Some hospitals in the north of the country, the region at the epicenter of the outbreak, have been forced to install additional large storage tanks to ensure an adequate supply.

In the U.K., one major London hospital reportedly came close to exhausting its oxygen supply last weekend. This resulted in an urgent letter from the National Health Service instructing doctors to calculate the maximum number of patients they can support on oxygen at any one time, and to limit the use of continuous positive airway pressure (CPAP) machines, which doctors have been using to help patients who are not yet sick enough to require a ventilator.

CPAP machines and other forms of what’s known as “high-flow nasal oxygen,” which deliver oxygen directly into a patient’s nostrils through tubing, often consume far more oxygen per hour than ventilators. Hooking too many patients up to high-flow piped oxygen simultaneously can also create pressure imbalances across the hospital’s oxygen network, leading the entire system to suddenly fail, jeopardizing all the patients in the hospital who are currently receiving wall-based oxygen, the NHS said.

The NHS warning raises the prospect that even if the U.K. is able to produce enough ventilators to meet the demand from coronavirus patients, the available supply of oxygen may ultimately become a limiting factor in the number of patients able to receive lifesaving treatment.

Meanwhile, in New York City, a number of doctors have said their hospitals have also come perilously close to running out of piped oxygen. They have reported running low on oxygen canisters, which some hospitals have begun using to treat patients because all of their piped oxygen connections are already in use.

Biju Mohan, a vice president at GEP, a global supply-chain consulting firm based in Clark, N.J., and a specialist in the pharmaceutical and health care industries, said estimates of the surge in demand for medical oxygen range widely between 25% and 500%. He said most manufacturers operate with about 20% spare capacity during normal times and that they should have the ability to meet the surging hospital requirements, especially as demand from other users, such as the construction and oil and gas industry, has plummeted as the economy has ground to a halt.

Pulled from the air

In theory, there are few limits on the amount of oxygen manufacturers can produce. Most producers take in air from the atmosphere, filter it, and then use a cryogenic process, in which the air is cooled to extreme temperatures by an air compressor to separate it into its constituent gases, such as oxygen and nitrogen. These are then further purified and distilled into a liquid or bottled in pressurized cylinders and small canisters. Most of the process is driven by basic physics and heat, with few chemical supplies involved.

The bigger practical problem, Mohan said, is that hospitals normally receive oxygen in liquid form, which is then evaporated into gas and piped throughout the hospital. Hospitals have limited storage capacity for liquid oxygen, and delivery fleets are having to make many more trips than normal to keep these tanks filled, he says.

Ganesh Suntharalingam, a doctor who is president of the U.K.’s Intensive Care Society, said during an online seminar sponsored by the Association of Anaesthetists earlier this month, that most hospitals’ oxygen tanks have sensors that automatically order more supply when tank levels drop to a certain threshold. But with the rate of oxygen depletion much higher than normal—and high demand from so many hospitals occurring at the same time—“for that hospital to not run out that day is going to be a challenge.”

In some cases, he said, hospitals could find their oxygen supplies completely depleted “within hours rather than days.”

Mohan said that it should be possible for hospitals to supplement their piped oxygen supplies with large cylinders of oxygen, which are normally used for industrial customers, but that there are regulatory obstacles to doing so—these cylinders are not licensed for use in medical settings. Air Liquide, one of the world’s largest medical gas suppliers, has said it is considering asking for regulatory approval to do this.

In the U.K., the government has asked BOC, an oxygen producer and official supplier to the National Health Service, to quadruple production to meet the anticipated demand as coronavirus cases peak in the coming weeks. “BOC is working closely with government departments within the U.K. to develop processes and procedures to cope with an increased demand of medical gases associated with the current COVID-19 outbreak,” the company, which is a subsidiary of Linde, one of the world’s largest industrial gas producers, said in a statement.

BOC has been building up stocks of medical gases in preparation for the pandemic, the company said, and has also increased its fleet of tankers for trucking gas to hospitals. The British military has been placed on standby to help drive oxygen tankers if BOC’s own drivers start to fall ill or have to self-isolate.

BOC and Air Liquide have both asked medical customers who use oxygen gas in canisters to return empty ones promptly so they can be refilled and sent out again.

Air Products, another major industrial gases producer headquartered in Allentown, Pa., said in a statement that it is “not currently experiencing any production shortages” owing to the pandemic and that it “continues to review and evaluate its entire robust supply chain, redundant backup plans, and network of facilities to meet customers’ demands.

“This is a dynamic and fluid situation, which makes it difficult to predict its future impact or exact duration,” the company said.

热读文章
热门视频
扫描二维码下载财富APP